Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 August 2004, Vol. 104, No. 3, pp. 687-695.
Prepublished online as a Blood First Edition Paper on April 13, 2004; DOI 10.1182/blood-2003-12-4344.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-12-4344v1
104/3/687    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodrum, F.
Right arrow Articles by Shenk, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodrum, F.
Right arrow Articles by Shenk, T.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Gene Expression
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMATOPOIESIS

Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations

Felicia Goodrum, Craig T. Jordan, Scott S. Terhune, Kevin High, and Thomas Shenk

From the Department of Molecular Biology, Princeton University, Princeton, NJ; the Department of Medicine, University of Rochester School of Medicine, Rochester, NY; and the Department of Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, NC.

The cellular reservoir for latent human cytomegalovirus (HCMV) in the hematopoietic compartment, and the mechanisms governing a latent infection and reactivation from latency are unknown. Previous work has demonstrated that HCMV infects CD34+ progenitors and expresses a limited subset of viral genes. The outcome of HCMV infection may depend on the cell subpopulations infected within the heterogeneous CD34+ compartment. We compared HCMV infection in well-defined CD34+ cell subpopulations. HCMV infection inhibited hematopoietic colony formation from CD34+/CD38 but not CD34+/c-kit+ cells. CD34+/CD38 cells transiently expressed a large subset of HCMV genes that were not expressed in CD34+/c-kit+ cells or cells expressing more mature cell surface phenotypes. Although viral genomes were present in infected cells, viral gene expression was undetectable by 10 days after infection. Importantly, viral replication could be reactivated by coculture with permissive fibroblasts only from the CD34+/CD38 population. Strikingly, a subpopulation of CD34+/CD38 cells expressing a stem cell phenotype (lineage/Thy-1+) supported a productive HCMV infection. These studies demonstrate that the outcome of HCMV infection in the hematopoietic compartment is dependent on the nature of the cell subpopulations infected and that CD34+/CD38 cells support an HCMV infection with the hallmarks of latency.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. K. L. Cheung, D. J. Gottlieb, B. Plachter, S. Pepperl-Klindworth, S. Avdic, A. L. Cunningham, A. Abendroth, and B. Slobedman
The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency
Blood, November 5, 2009; 114(19): 4128 - 4137.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Petrucelli, M. Rak, L. Grainger, and F. Goodrum
Characterization of a Novel Golgi Apparatus-Localized Latency Determinant Encoded by Human Cytomegalovirus
J. Virol., June 1, 2009; 83(11): 5615 - 5629.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Frascaroli, S. Varani, N. Blankenhorn, R. Pretsch, M. Bacher, L. Leng, R. Bucala, M. P. Landini, and T. Mertens
Human Cytomegalovirus Paralyzes Macrophage Motility through Down-Regulation of Chemokine Receptors, Reorganization of the Cytoskeleton, and Release of Macrophage Migration Inhibitory Factor
J. Immunol., January 1, 2009; 182(1): 477 - 488.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Stern and B. Slobedman
Human Cytomegalovirus Latent Infection of Myeloid Cells Directs Monocyte Migration by Up-Regulating Monocyte Chemotactic Protein-1
J. Immunol., May 15, 2008; 180(10): 6577 - 6585.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Goodrum, M. Reeves, J. Sinclair, K. High, and T. Shenk
Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro
Blood, August 1, 2007; 110(3): 937 - 945.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. N. Streblow, K. W. R. van Cleef, C. N. Kreklywich, C. Meyer, P. Smith, V. Defilippis, F. Grey, K. Fruh, R. Searles, C. Bruggeman, et al.
Rat Cytomegalovirus Gene Expression in Cardiac Allograft Recipients Is Tissue Specific and Does Not Parallel the Profiles Detected In Vitro
J. Virol., April 15, 2007; 81(8): 3816 - 3826.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Terhune, E. Torigoi, N. Moorman, M. Silva, Z. Qian, T. Shenk, and D. Yu
Human Cytomegalovirus UL38 Protein Blocks Apoptosis
J. Virol., April 1, 2007; 81(7): 3109 - 3123.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. K. L. Cheung, A. Abendroth, A. L. Cunningham, and B. Slobedman
Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells
Blood, December 1, 2006; 108(12): 3691 - 3699.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Frascaroli, S. Varani, B. Moepps, C. Sinzger, M. P. Landini, and T. Mertens
Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment.
J. Virol., August 1, 2006; 80(15): 7578 - 7589.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. Sinclair and P. Sissons
Latency and reactivation of human cytomegalovirus
J. Gen. Virol., July 1, 2006; 87(7): 1763 - 1779.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Wu, J. Vieira, N. Fiore, P. Banerjee, M. Sieburg, R. Rochford, W. Harrington Jr, and G. Feuer
KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo
Blood, July 1, 2006; 108(1): 141 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Tripp, P. Banerjee, M. Sieburg, V. Planelles, F. Li, and G. Feuer
Induction of Cell Cycle Arrest by Human T-Cell Lymphotropic Virus Type 1 Tax in Hematopoietic Progenitor (CD34+) Cells: Modulation of p21cip1/waf1 and p27kip1 Expression
J. Virol., November 15, 2005; 79(22): 14069 - 14078.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. B. Reeves, P. J. Lehner, J. G. P. Sissons, and J. H. Sinclair
An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling
J. Gen. Virol., November 1, 2005; 86(11): 2949 - 2954.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020